Biomaterial Database

Cinnoline derivatives as human neutrophil elastase inhibitors. 2016

Maria Paola Giovannoni, and Igor A Schepetkin, and Letizia Crocetti, and Giovanna Ciciani, and Agostino Cilibrizzi, and Gabriella Guerrini, and Andrei I Khlebnikov, and Mark T Quinn, and Claudia Vergelli

a NEUROFARBA, Sezione di Farmaceutica e Nutraceutica, Università degli Studi di Firenze , Sesto Fiorentino , Italy .

Compounds that can effectively inhibit the proteolytic activity of human neutrophil elastase (HNE) represent promising therapeutics for treatment of inflammatory diseases. We present here the synthesis, structure-activity relationship analysis, and biological evaluation of a new series of HNE inhibitors with a cinnoline scaffold. These compounds exhibited HNE inhibitory activity but had lower potency compared to N-benzoylindazoles previously reported by us. On the other hand, they exhibited increased stability in aqueous solution. The most potent compound, 18a, had a good balance between HNE inhibitory activity (IC50 value = 56 nM) and chemical stability (t1/2 = 114 min). Analysis of reaction kinetics revealed that these cinnoline derivatives were reversible competitive inhibitors of HNE. Furthermore, molecular docking studies of the active products into the HNE binding site revealed two types of HNE inhibitors: molecules with cinnolin-4(1H)-one scaffold, which were attacked by the HNE Ser195 hydroxyl group at the amido moiety, and cinnoline derivatives containing an ester function at C-4, which is the point of attack of Ser195.

UI	MeSH Term	Description	Entries
D008958	Models, Molecular	Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.	Molecular Models,Model, Molecular,Molecular Model
D004305	Dose-Response Relationship, Drug	The relationship between the dose of an administered drug and the response of the organism to the drug.	Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006574	Heterocyclic Compounds, 2-Ring	A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category.	Fused Heterocyclic Compounds, Two-Ring,Two Ring Heterocyclic Compounds,2-Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Two Ring,Heterocyclic Compounds, 2 Ring
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329	Structure-Activity Relationship	The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.	Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394	Molecular Structure	The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.	Structure, Molecular,Molecular Structures,Structures, Molecular
D053491	Proteinase Inhibitory Proteins, Secretory	Peptides and proteins found in BODILY SECRETIONS and BODY FLUIDS that are PROTEASE INHIBITORS. They play a role in INFLAMMATION, tissue repair and innate immunity (IMMUNITY, INNATE) by inhibiting endogenous proteinases such as those produced by LEUKOCYTES and exogenous proteases such as those produced by invading microorganisms.	Neutrophil Elastase Inhibitor,Neutrophil Elastase Inhibitors,Proteinase Inhibitory Peptides, Secretory,Peptidase Inhibitory Peptides, Secretory,Peptidase Inhibitory Proteins, Secretory,Protease Inhibitory Peptides, Secretory,Protease Inhibitory Proteins, Secretory,Elastase Inhibitor, Neutrophil,Elastase Inhibitors, Neutrophil,Inhibitor, Neutrophil Elastase,Inhibitors, Neutrophil Elastase
D019272	Leukocyte Elastase	An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.	Lysosomal Elastase,Neutrophil Elastase,PMN Elastase,Polymorphonuclear Leukocyte Elastase,Granulocyte Elastase,Elastase, Granulocyte,Elastase, Leukocyte,Elastase, Lysosomal,Elastase, Neutrophil,Elastase, PMN,Elastase, Polymorphonuclear Leukocyte,Leukocyte Elastase, Polymorphonuclear

Related Publications

Flavonoids as inhibitors of human neutrophil elastase.

December 2021, Journal of enzyme inhibition and medicinal chemistry,

Synthesis and evaluation of benzenesulfonic acid derivatives as human neutrophil elastase (hNE) inhibitors.

January 2021, Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents,

Diazaborines as New Inhibitors of Human Neutrophil Elastase.

July 2018, ACS omega,

Sesquiterpene lactones as inhibitors of human neutrophil elastase.

September 2002, Bioorganic & medicinal chemistry,

Natural compounds as inhibitors of human neutrophil elastase.

May 2007, Planta medica,

Triterpenoids as neutrophil elastase inhibitors.

January 2015, Natural product communications,

Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors.

December 2013, Journal of medicinal chemistry,

Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach.

February 2011, Bioorganic & medicinal chemistry,